Targeting Obesity With the Probiotic Lactiplantibacillus Plantarum IMC 510 (PRO-Weight-Control Study)

NACompletedINTERVENTIONAL
Enrollment

40

Participants

Timeline

Start Date

January 7, 2022

Primary Completion Date

June 30, 2022

Study Completion Date

October 31, 2022

Conditions
Obesity
Interventions
DIETARY_SUPPLEMENT

Probiotic

Probiotic food supplement produced by SYNBIOTEC S.r.l. Each capsule of SYNBIO®slim contains the probiotic strain Lactiplantibacillus Plantarum IMC 510 at a concentration of 15 billion live cells (CFU/capsule). The assumption is of n°1 capsule/day, preferably at breakfast, for 3 months. The capsules can be opened and their content can be dispersed in a cold liquid or at intake temperature or in semi-solid food. Always store in original container or in a clean covered container, out of the reach of children. When stored in a dry, clean environment, out of direct sunlight, the product has a shelf-life of at least 24 months. Samples of probiotic supplement in closed and sealed boxes will be provided to subjects participating at the beginning of the study, in quantities sufficient for the entire duration of the study (90 capsules for 3 months).

DIETARY_SUPPLEMENT

Placebo

N°1 capsule/day of placebo food supplement (i.e., capsules without added probiotics), with the same intake modalities as probiotic.

Trial Locations (1)

50134

Unit of Clinical Nutrition, University Hospital of Careggi, Florence

All Listed Sponsors
lead

Azienda Ospedaliero-Universitaria Careggi

OTHER

NCT05358301 - Targeting Obesity With the Probiotic Lactiplantibacillus Plantarum IMC 510 (PRO-Weight-Control Study) | Biotech Hunter | Biotech Hunter